Hospitalizations for respiratory syncytial virus bronchiolitis in preterm infants at <33 weeks gestation without bronchopulmonary dysplasia: the CASTOR study.
about
Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta-analysisDefining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart DiseaseRespiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysisRespiratory Syncytial Virus Hospitalizations in Healthy Preterm Infants: Systematic Review.Evaluation of recent New Vaccine Surveillance Network data regarding respiratory syncytial virus hospitalization rates in US preterm infantsRespiratory Syncytial Virus Bronchiolitis in Children up to 5 Years of Age in Spain: Epidemiology and Comorbidities: An Observational Study.Respiratory syncytial virus infection in infants in rural Nepal.Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for prevention.Prematurity and the burden of influenza and respiratory syncytial virus disease.Is radiological appearance of lower respiratory tract infection due to respiratory syncytial virus a predictor of clinical outcome?Maternal inflammation modulates infant immune response patterns to viral lung challenge in a murine model.Respiratory morbidity of preterm infants of less than 33 weeks gestation without bronchopulmonary dysplasia: a 12-month follow-up of the CASTOR study cohort.Immune function? A missing link in the gender disparity in preterm neonatal outcomes.Seasonal peaks and risk factors of respiratory syncytial virus infections related hospitalization of preterm infants in Taiwan.The impact of respiratory viruses on lung health after preterm birth
P2860
Q26774885-C1B8CB0E-D5DE-4DCF-9E2B-158E17B96562Q28072535-A9F287DA-E989-488E-A2E4-E215C7C3E090Q30244591-DDA33BD1-6F0C-4142-AFCE-14F78E33C187Q30251560-A1D40190-FCA7-4270-B570-52A16F3D46D8Q31047460-B0DDC9EC-A570-4D3B-A5AB-3EA7D8775E7DQ36193981-FBD0DE2C-7583-417F-8C2A-5A1A5DC68318Q37088637-CA5E4149-BEEA-4D1F-BAB9-D9DEAE963489Q38604949-DCD78407-4D2E-4BA9-B9D3-BB5A013DBFAFQ38637989-485CB909-34E6-4301-909B-2A47393A94A2Q41743214-0A857663-5C7C-45F0-BE5A-7670C140DFC5Q42224853-E94FBB9D-8290-46AF-B6ED-D98B04E31D47Q42270216-800159B2-E5F2-4CB9-A250-8E45938AF4CBQ47755276-B2BAD4D6-2726-4689-A928-11B85C28EB10Q54215865-8A54D1C2-59AE-4571-9D86-355D3B7387EBQ57026345-968ED78F-0861-4D06-B7D8-8B3DD7DD971F
P2860
Hospitalizations for respiratory syncytial virus bronchiolitis in preterm infants at <33 weeks gestation without bronchopulmonary dysplasia: the CASTOR study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Hospitalizations for respirato ...... y dysplasia: the CASTOR study.
@ast
Hospitalizations for respirato ...... y dysplasia: the CASTOR study.
@en
type
label
Hospitalizations for respirato ...... y dysplasia: the CASTOR study.
@ast
Hospitalizations for respirato ...... y dysplasia: the CASTOR study.
@en
prefLabel
Hospitalizations for respirato ...... y dysplasia: the CASTOR study.
@ast
Hospitalizations for respirato ...... y dysplasia: the CASTOR study.
@en
P2093
P2860
P921
P1476
Hospitalizations for respirato ...... ry dysplasia: the CASTOR study
@en
P2093
C Guillermet-Fromentin
D Anghelescu
D Pinquier
I Glorieux
J-B Gouyon
T Miloradovich
P2860
P304
P356
10.1017/S0950268812001069
P577
2012-06-15T00:00:00Z